Prellis Biologics Company
Prellis Biologics builds human tissues for drug development, and develops human organs for transplantation.
Investors
Connections from
Founded Date:
2016-01-01
Total Funding:
29872758
Employee Number:
11-50
Technology:
Small Molecules
Last Funding Type:
Venture - Series Unknown
Investors Number:
8
Last Funding Date:
2021
Industry:
3D Printing, Biotechnology, Health Care, Medical, PharmTech
Headquarters:
San Francisco Bay Area, West Coast, Western US
Estimated Revenue:
Less than $1M